Improving brain tumor imaging using advanced techniques
Development of Quantitative Deuterium MRS Imaging for Human Brain Tumor Application at Ultrahigh Field
This study is testing a new way to take pictures of brain tumors, especially glioblastomas, using a special substance called deuterium, to help doctors see how the tumors are changing and how well treatments are working, all without needing any invasive procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10686390 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging technique that uses deuterium to noninvasively assess brain tumors, particularly glioblastoma, which is known for its aggressive nature and resistance to standard treatments. By characterizing the metabolic changes in these tumors, the research aims to provide insights into tumor progression and treatment response without the need for invasive procedures. The approach leverages advanced neuroimaging methods to visualize the unique metabolic features of cancer cells, specifically their altered glucose metabolism. This could significantly enhance the ability to monitor and treat brain tumors effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are undergoing treatment or monitoring for their condition.
Not a fit: Patients with other types of brain tumors or those not diagnosed with glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better monitoring and treatment strategies for patients with glioblastoma, potentially improving survival rates.
How similar studies have performed: Previous research has shown promise in using metabolic imaging techniques for cancer treatment, indicating that this approach could be a significant advancement in the field.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Chen, Wei — University of Minnesota
- Study coordinator: Chen, Wei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.